AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $56,000 | +143.5% | 3,728 | +20.0% | 0.00% | +200.0% |
| Q2 2022 | $23,000 | -17.9% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $28,000 | +27.3% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $22,000 | -37.1% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | -30.0% | 3,106 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $50,000 | -10.7% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $56,000 | +14.3% | 3,106 | -13.9% | 0.00% | 0.0% |
| Q4 2020 | $49,000 | +16.7% | 3,606 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $42,000 | -20.8% | 3,606 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $53,000 | +8.2% | 3,606 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $49,000 | -43.7% | 3,606 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $87,000 | +26.1% | 3,606 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $69,000 | -35.5% | 3,606 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $107,000 | -24.1% | 3,606 | +21.7% | 0.01% | -28.6% |
| Q1 2019 | $141,000 | +31.8% | 2,964 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $107,000 | -41.2% | 2,964 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $182,000 | -9.0% | 2,964 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $200,000 | +31.6% | 2,964 | +5.7% | 0.01% | +42.9% |
| Q1 2018 | $152,000 | -9.5% | 2,805 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $168,000 | +10.5% | 2,805 | +5.3% | 0.01% | +14.3% |
| Q3 2017 | $152,000 | +8.6% | 2,665 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $140,000 | +29.6% | 2,665 | +11.5% | 0.01% | +40.0% |
| Q1 2017 | $108,000 | – | 2,390 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |